| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 2,042,800 | 1,766,200 | 1,801,500 | 1,787,300 | 1,781,700 |
| Sales Growth | +15.66% | -1.96% | +0.79% | +0.31% | unch |
| Net Income | -54,300 | -211,900 | -156,900 | -248,800 | -116,300 |
| Net Income Growth | +74.37% | -35.05% | +36.94% | -113.93% | unch |
Ortho Clinical Diagnostics Plc (OCDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ortho Clinical Diagnostics deals with in vitro and in vivo diagnostic substances.
Fiscal Year End Date: 12/31